about
LIM Kinase Inhibitor Pyr1 Reduces the Growth and Metastatic Load of Breast Cancers.Evaluation of Antiatherogenic Properties of Ezetimibe Using 3H-Labeled Low-Density-Lipoprotein Cholesterol and 99mTc-cAbVCAM1-5 SPECT in ApoE-/- Mice Fed the Paigen Diet.Metastatic Heterogeneity of Breast Cancer: Companion and Theranostic Approach in Nuclear Medicine99mTc-A1 as a Novel Imaging Agent Targeting Mesothelin-Expressing Pancreatic Ductal AdenocarcinomaIn Vivo Assessment of VCAM-1 Expression by SPECT/CT Imaging in Mice Models of Human Triple Negative Breast CancerFrom Malignant Progression to Therapeutic Targeting: Current Insights of Mesothelin in Pancreatic Ductal Adenocarcinoma
P50
description
researcher (ORCID 0000-0002-5687-1812)
@en
wetenschapper
@nl
name
Christopher Montemagno
@en
Christopher Montemagno
@nl
type
label
Christopher Montemagno
@en
Christopher Montemagno
@nl
prefLabel
Christopher Montemagno
@en
Christopher Montemagno
@nl
P31
P496
0000-0002-5687-1812